Bajaj Healthcare Limited — Important, 06-12-2024: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

Bajaj Healthcare Limited's API manufacturing site in Gujarat has received approval from the Therapeutic Goods Administration (TGA) of Australia, complementing its existing certifications from the USFDA and EU. This milestone enhances the company’s position as a global supplier of APIs, enabling direct supplies to Australia and New Zealand. The approval is expected to attract more contract manufacturing opportunities from current and potential clients, signaling a positive outlook for growth. Investors might view this development favorably due to the expanded market access and growth potential in a competitive landscape.